We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Artificial Intelligence Detects Heart Defects in Newborns from Ultrasound Images

By MedImaging International staff writers
Posted on 14 Mar 2024
Print article
Image: A cardiac ultrasound examination being performed on a 7-week old infant (Photo courtesy of ETH Zurich)
Image: A cardiac ultrasound examination being performed on a 7-week old infant (Photo courtesy of ETH Zurich)

Pulmonary hypertension is a condition where the arteries going to an infant’s lungs don't open wide enough or close back up soon after birth. This makes it hard for blood to get to the lungs and for the infant to get enough oxygen. It's really important to find and treat this problem quickly to help the infant get better. However, figuring out if an infant has pulmonary hypertension is tough and usually only very skilled heart doctors can do it by looking at heart ultrasounds. Now, researchers have developed an artificial intelligence (AI) model that can help diagnose the disease in newborns.

Researchers at ETH Zurich (Zurich, Switzerland) developed the AI model by training their algorithm on videos from heart ultrasound recordings of 192 newborns. These videos showed the heart beating from different sides and included the heart doctors' views on whether the baby had pulmonary hypertension and the severity of the condition. Then, they tested the AI model using a second dataset of ultrasound images from 78 newborn infants. The AI model correctly diagnosed whether the baby had pulmonary hypertension in about 80 to 90% of the cases and was also correct about the severity in about 65 to 85% of cases.

The AI model also highlights the parts of the ultrasound image on which its categorization is based, allowing doctors to know exactly which areas or characteristics of the heart and its blood vessels it considers suspicious. This AI model could be potentially applied to other organs and diseases, such as for diagnosing heart septal defects or valvular heart disease. It could also find application in regions where specialists are unavailable: the model could examine standardized ultrasound images taken by a healthcare professional and provide a preliminary risk assessment along with an indication of whether a specialist should be consulted. Medical facilities without access to highly qualified specialists could use the AI model to reduce their workload and achieve a better diagnosis.

“The key to using a machine-​learning model in a medical context is not just the prediction accuracy, but also whether humans are able to understand the criteria the model uses to make decisions,” said Julia Vogt from ETH Zurich who led the research group. “AI has the potential to make significant improvements to healthcare. The crucial issue for us is that the final decision should always be made by a human, by a doctor. AI should simply be providing support to ensure that the maximum number of people can receive the best possible medical care.”

Related Links:
ETH Zurich

Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Ergonomic Advantage (EA) Line
Color Doppler Ultrasound System
DRE Crystal 4PX
New
Ultrasound System
Voluson Signature 18

Print article
Radcal

Channels

MRI

view channel
Image: The emerging role of MRI alongside PSA testing is redefining prostate cancer diagnostics (Photo courtesy of 123RF)

Combining MRI with PSA Testing Improves Clinical Outcomes for Prostate Cancer Patients

Prostate cancer is a leading health concern globally, consistently being one of the most common types of cancer among men and a major cause of cancer-related deaths. In the United States, it is the most... Read more

Nuclear Medicine

view channel
Image: The new SPECT/CT technique demonstrated impressive biomarker identification (Journal of Nuclear Medicine: doi.org/10.2967/jnumed.123.267189)

New SPECT/CT Technique Could Change Imaging Practices and Increase Patient Access

The development of lead-212 (212Pb)-PSMA–based targeted alpha therapy (TAT) is garnering significant interest in treating patients with metastatic castration-resistant prostate cancer. The imaging of 212Pb,... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.